Takeda announces 1,000 job cuts after acquiring Shire

Takeda Pharmaceuticals yesterday evening announced it plans to close down its Deerfield (Chicago) headquarters, cutting 1,000 jobs. The announcement came as no surprise to analysts, who were expecting a radical cost cut after the $62bn acquisition of Shire. Soon after the announcement, Takeda informed that it would cut at least 7% of its workforce due to the Shire deal.

Takeda had already relocated some key positions from Deerfield to Boston HQ. In addition to the Boston HQ, Takeda in the US has a R&D center in San Diego, a production site in Minnesota and an administration site in Washington, D.C.

(Sources: Chicago Tribune, Chicago Business)